

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 6.65289303 |
| 2 | cardiac myofibril assembly (GO:0055003) | 6.58566588 |
| 3 | myofibril assembly (GO:0030239) | 6.01481152 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.92785846 |
| 5 | actin-myosin filament sliding (GO:0033275) | 5.78194135 |
| 6 | muscle filament sliding (GO:0030049) | 5.78194135 |
| 7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.27853679 |
| 8 | plasma membrane repair (GO:0001778) | 5.25200898 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 5.19882620 |
| 10 | actin-mediated cell contraction (GO:0070252) | 4.93265131 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.84009012 |
| 12 | actomyosin structure organization (GO:0031032) | 4.76015958 |
| 13 | cardiac muscle contraction (GO:0060048) | 4.69190134 |
| 14 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.64096545 |
| 15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.64036226 |
| 16 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.57078646 |
| 17 | cardiac muscle cell development (GO:0055013) | 4.54487323 |
| 18 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.32442281 |
| 19 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.32038983 |
| 20 | cardiac cell development (GO:0055006) | 4.30795073 |
| 21 | regulation of actin filament-based movement (GO:1903115) | 4.29254737 |
| 22 | carnitine shuttle (GO:0006853) | 4.22019297 |
| 23 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.21710351 |
| 24 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.08523309 |
| 25 | actin filament-based movement (GO:0030048) | 4.07881084 |
| 26 | adult heart development (GO:0007512) | 4.02184882 |
| 27 | regulation of sarcomere organization (GO:0060297) | 4.02164115 |
| 28 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.98549977 |
| 29 | negative regulation of protein localization to cell surface (GO:2000009) | 3.97866031 |
| 30 | regulation of cardioblast differentiation (GO:0051890) | 3.95361967 |
| 31 | heart trabecula formation (GO:0060347) | 3.95294736 |
| 32 | striated muscle contraction (GO:0006941) | 3.94990169 |
| 33 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.89783354 |
| 34 | creatine metabolic process (GO:0006600) | 3.89643575 |
| 35 | muscle tissue morphogenesis (GO:0060415) | 3.88169177 |
| 36 | cardiac muscle hypertrophy (GO:0003300) | 3.88069791 |
| 37 | cell communication involved in cardiac conduction (GO:0086065) | 3.86118001 |
| 38 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.83311666 |
| 39 | regulation of relaxation of muscle (GO:1901077) | 3.77747983 |
| 40 | fatty acid transmembrane transport (GO:1902001) | 3.77722380 |
| 41 | striated muscle hypertrophy (GO:0014897) | 3.73643605 |
| 42 | regulation of membrane repolarization (GO:0060306) | 3.63348568 |
| 43 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.62064117 |
| 44 | tricarboxylic acid cycle (GO:0006099) | 3.54530970 |
| 45 | regulation of cell communication by electrical coupling (GO:0010649) | 3.53523154 |
| 46 | regulation of striated muscle contraction (GO:0006942) | 3.51321628 |
| 47 | hemidesmosome assembly (GO:0031581) | 3.42098229 |
| 48 | cell communication by electrical coupling (GO:0010644) | 3.35573638 |
| 49 | regulation of the force of heart contraction (GO:0002026) | 3.27656537 |
| 50 | muscle hypertrophy (GO:0014896) | 3.22214827 |
| 51 | cardiac muscle cell action potential (GO:0086001) | 3.20573322 |
| 52 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.17772642 |
| 53 | desmosome organization (GO:0002934) | 3.16667176 |
| 54 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.15855523 |
| 55 | carnitine transmembrane transport (GO:1902603) | 3.12917425 |
| 56 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.06443645 |
| 57 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.05117732 |
| 58 | regulation of p38MAPK cascade (GO:1900744) | 3.03063774 |
| 59 | focal adhesion assembly (GO:0048041) | 3.01225513 |
| 60 | cell-substrate adherens junction assembly (GO:0007045) | 3.01225513 |
| 61 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.98285521 |
| 62 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.97893203 |
| 63 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.97057056 |
| 64 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.97007518 |
| 65 | macroautophagy (GO:0016236) | 2.95497319 |
| 66 | cardiac conduction (GO:0061337) | 2.95050695 |
| 67 | membrane tubulation (GO:0097320) | 2.94070426 |
| 68 | hypotonic response (GO:0006971) | 2.93157104 |
| 69 | muscle contraction (GO:0006936) | 2.92481919 |
| 70 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.91739183 |
| 71 | skeletal muscle contraction (GO:0003009) | 2.90759580 |
| 72 | relaxation of cardiac muscle (GO:0055119) | 2.90632124 |
| 73 | skeletal muscle adaptation (GO:0043501) | 2.87916646 |
| 74 | skin morphogenesis (GO:0043589) | 2.85020613 |
| 75 | adherens junction assembly (GO:0034333) | 2.84886751 |
| 76 | carnitine transport (GO:0015879) | 2.83287657 |
| 77 | amino-acid betaine transport (GO:0015838) | 2.83287657 |
| 78 | regulation of heart rate (GO:0002027) | 2.82619427 |
| 79 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.82030340 |
| 80 | muscle hypertrophy in response to stress (GO:0003299) | 2.82030340 |
| 81 | cardiac muscle adaptation (GO:0014887) | 2.82030340 |
| 82 | response to muscle activity (GO:0014850) | 2.80592513 |
| 83 | trabecula formation (GO:0060343) | 2.79646212 |
| 84 | cell adhesion mediated by integrin (GO:0033627) | 2.79084096 |
| 85 | response to inactivity (GO:0014854) | 2.79079041 |
| 86 | epithelial cell-cell adhesion (GO:0090136) | 2.78565752 |
| 87 | regulation of cardiac muscle contraction (GO:0055117) | 2.78055745 |
| 88 | endodermal cell differentiation (GO:0035987) | 2.73539844 |
| 89 | negative regulation of fatty acid transport (GO:2000192) | 2.73195870 |
| 90 | striated muscle adaptation (GO:0014888) | 2.71550197 |
| 91 | muscle system process (GO:0003012) | 2.70031116 |
| 92 | potassium ion import (GO:0010107) | 2.69104821 |
| 93 | striated muscle cell development (GO:0055002) | 2.68478691 |
| 94 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.67697787 |
| 95 | cellular response to epinephrine stimulus (GO:0071872) | 2.66351404 |
| 96 | cell-substrate junction assembly (GO:0007044) | 2.65767621 |
| 97 | heart process (GO:0003015) | 2.65548997 |
| 98 | heart contraction (GO:0060047) | 2.65548997 |
| 99 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.64948282 |
| 100 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 2.63792556 |
| 101 | gap junction assembly (GO:0016264) | 2.63572285 |
| 102 | glomerular filtration (GO:0003094) | 2.62631961 |
| 103 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.62614132 |
| 104 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.62614132 |
| 105 | negative regulation of potassium ion transport (GO:0043267) | 2.62582596 |
| 106 | protein localization to endosome (GO:0036010) | 2.62463673 |
| 107 | renal filtration (GO:0097205) | 2.61778598 |
| 108 | regulation of sequestering of triglyceride (GO:0010889) | 2.59704406 |
| 109 | regulation of heart contraction (GO:0008016) | 2.57878800 |
| 110 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.57716101 |
| 111 | basement membrane organization (GO:0071711) | 2.57381614 |
| 112 | heart morphogenesis (GO:0003007) | 2.55013417 |
| 113 | positive regulation of receptor recycling (GO:0001921) | 2.53794255 |
| 114 | intracellular lipid transport (GO:0032365) | 2.51106679 |
| 115 | import into cell (GO:0098657) | 2.50343419 |
| 116 | outflow tract septum morphogenesis (GO:0003148) | 2.47510583 |
| 117 | positive regulation of cation channel activity (GO:2001259) | 2.45911694 |
| 118 | response to epinephrine (GO:0071871) | 2.44072085 |
| 119 | glycogen catabolic process (GO:0005980) | 2.42468885 |
| 120 | iron ion import (GO:0097286) | 2.42299272 |
| 121 | cell migration involved in heart development (GO:0060973) | 2.41363690 |
| 122 | endocardial cushion development (GO:0003197) | 2.39704384 |
| 123 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.39537832 |
| 124 | striated muscle atrophy (GO:0014891) | 2.39355508 |
| 125 | glucan catabolic process (GO:0009251) | 2.39175170 |
| 126 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.37795127 |
| 127 | myoblast fusion (GO:0007520) | 2.36612618 |
| 128 | paraxial mesoderm development (GO:0048339) | 2.33468860 |
| 129 | cellular polysaccharide catabolic process (GO:0044247) | 2.33088273 |
| 130 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.31834333 |
| 131 | surfactant homeostasis (GO:0043129) | 2.31151702 |
| 132 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.29141888 |
| 133 | atrioventricular valve morphogenesis (GO:0003181) | 2.28753416 |
| 134 | collagen fibril organization (GO:0030199) | 2.27750029 |
| 135 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.24829063 |
| 136 | regulation of tight junction assembly (GO:2000810) | 2.24151505 |
| 137 | positive regulation of myotube differentiation (GO:0010831) | 2.23436607 |
| 138 | skeletal muscle tissue development (GO:0007519) | 2.20387988 |
| 139 | positive regulation of osteoblast proliferation (GO:0033690) | 2.20065958 |
| 140 | negative regulation of vascular permeability (GO:0043116) | 2.18445911 |
| 141 | negative regulation of complement activation (GO:0045916) | 2.17933230 |
| 142 | chemical homeostasis within a tissue (GO:0048875) | 2.17320711 |
| 143 | skeletal muscle fiber development (GO:0048741) | 2.15478795 |
| 144 | extracellular matrix assembly (GO:0085029) | 2.15258798 |
| 145 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.14656437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.63428386 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.33003855 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.87647929 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.66961139 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.66961139 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.52634837 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.49670318 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.34342121 |
| 9 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 2.31090462 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15680335 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.11890364 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.10542359 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.07500146 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00963357 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00357020 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99581582 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.98852917 |
| 18 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.94159347 |
| 19 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.91673624 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77607526 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73492749 |
| 22 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.67156260 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64380541 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63857282 |
| 25 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.57036552 |
| 26 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.56891090 |
| 27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.55205527 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.55167844 |
| 29 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55134562 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54830022 |
| 31 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.54601038 |
| 32 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.53403095 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.53296670 |
| 34 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51344367 |
| 35 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50338682 |
| 36 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.50284461 |
| 37 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46280415 |
| 38 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.44622304 |
| 39 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42993708 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.41454308 |
| 41 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40492293 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39819694 |
| 43 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.38493572 |
| 44 | TP53_16413492_ChIP-PET_HCT116_Human | 1.38033687 |
| 45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.37476376 |
| 46 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35398166 |
| 47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34228277 |
| 48 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31614662 |
| 49 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31206339 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31123940 |
| 51 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28579658 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.28378548 |
| 53 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.28286679 |
| 54 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.26521639 |
| 55 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24912173 |
| 56 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24677303 |
| 57 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.23187897 |
| 58 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.21483638 |
| 59 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20711237 |
| 60 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19306098 |
| 61 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.18119337 |
| 62 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17459870 |
| 63 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16877350 |
| 64 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.15988640 |
| 65 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.15306000 |
| 66 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.13905194 |
| 67 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12287493 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12003810 |
| 69 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.11838021 |
| 70 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.11355704 |
| 71 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10176404 |
| 72 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09797075 |
| 73 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09797075 |
| 74 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09222321 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07997238 |
| 76 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07971902 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07469389 |
| 78 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06703378 |
| 79 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05888105 |
| 80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04812325 |
| 81 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04362726 |
| 82 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04065976 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03817942 |
| 84 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.03354177 |
| 85 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.03236628 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02849699 |
| 87 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.01841279 |
| 88 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01738757 |
| 89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01634732 |
| 90 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01398606 |
| 91 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.01335292 |
| 92 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01146252 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99577274 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99577274 |
| 95 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99288249 |
| 96 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98906179 |
| 97 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98519764 |
| 98 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.98458453 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98070983 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97703837 |
| 101 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96745160 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96407686 |
| 103 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.95535354 |
| 104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.95515413 |
| 105 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95493739 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95380581 |
| 107 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94053432 |
| 108 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.93906498 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92860877 |
| 110 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92286709 |
| 111 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.91864715 |
| 112 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90717928 |
| 113 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90277472 |
| 114 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.88774873 |
| 115 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.88551904 |
| 116 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.88320105 |
| 117 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88013481 |
| 118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86778355 |
| 119 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86778355 |
| 120 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85370192 |
| 121 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85220014 |
| 122 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84999839 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84165315 |
| 124 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.82763177 |
| 125 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.81383399 |
| 126 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.81335097 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004084_abnormal_cardiac_muscle | 4.76332514 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.67934043 |
| 3 | MP0000751_myopathy | 4.57810002 |
| 4 | MP0004036_abnormal_muscle_relaxation | 3.82663286 |
| 5 | MP0004215_abnormal_myocardial_fiber | 3.54085248 |
| 6 | MP0000749_muscle_degeneration | 3.48960277 |
| 7 | MP0003646_muscle_fatigue | 3.44653511 |
| 8 | MP0005330_cardiomyopathy | 3.10938289 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.01969289 |
| 10 | MP0004087_abnormal_muscle_fiber | 2.96753343 |
| 11 | MP0004145_abnormal_muscle_electrophysio | 2.74116656 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.60186585 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.55253877 |
| 14 | MP0010630_abnormal_cardiac_muscle | 2.42531735 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.41968571 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.37810224 |
| 17 | MP0004130_abnormal_muscle_cell | 2.33319973 |
| 18 | MP0002106_abnormal_muscle_physiology | 2.30898828 |
| 19 | MP0003137_abnormal_impulse_conducting | 2.27599013 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.17344948 |
| 21 | MP0006138_congestive_heart_failure | 2.13369894 |
| 22 | MP0000747_muscle_weakness | 2.12129013 |
| 23 | MP0001544_abnormal_cardiovascular_syste | 2.10464709 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.10464709 |
| 25 | MP0002269_muscular_atrophy | 2.00238308 |
| 26 | MP0000759_abnormal_skeletal_muscle | 1.95882516 |
| 27 | MP0005369_muscle_phenotype | 1.95548232 |
| 28 | MP0004272_abnormal_basement_membrane | 1.94779686 |
| 29 | MP0003828_pulmonary_edema | 1.92320318 |
| 30 | MP0008438_abnormal_cutaneous_collagen | 1.91579412 |
| 31 | MP0005451_abnormal_body_composition | 1.90822580 |
| 32 | MP0010368_abnormal_lymphatic_system | 1.89155475 |
| 33 | MP0005409_darkened_coat_color | 1.84653883 |
| 34 | MP0004233_abnormal_muscle_weight | 1.77586138 |
| 35 | MP0004484_altered_response_of | 1.77467717 |
| 36 | MP0005503_abnormal_tendon_morphology | 1.69470940 |
| 37 | MP0004085_abnormal_heartbeat | 1.65315258 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.65118585 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.61125107 |
| 40 | MP0005257_abnormal_intraocular_pressure | 1.56328880 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.54427634 |
| 42 | MP0000733_abnormal_muscle_development | 1.53384161 |
| 43 | MP0005623_abnormal_meninges_morphology | 1.51558082 |
| 44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.47580712 |
| 45 | MP0005023_abnormal_wound_healing | 1.42599630 |
| 46 | MP0005275_abnormal_skin_tensile | 1.42052274 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.34525808 |
| 48 | MP0002896_abnormal_bone_mineralization | 1.32632351 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.31039738 |
| 50 | MP0003279_aneurysm | 1.29551567 |
| 51 | MP0003453_abnormal_keratinocyte_physiol | 1.27910370 |
| 52 | MP0002108_abnormal_muscle_morphology | 1.27892884 |
| 53 | MP0003567_abnormal_fetal_cardiomyocyte | 1.24493796 |
| 54 | MP0002796_impaired_skin_barrier | 1.22711246 |
| 55 | MP0002127_abnormal_cardiovascular_syste | 1.18637840 |
| 56 | MP0005670_abnormal_white_adipose | 1.16280644 |
| 57 | MP0002234_abnormal_pharynx_morphology | 1.14631285 |
| 58 | MP0002332_abnormal_exercise_endurance | 1.12119519 |
| 59 | MP0004510_myositis | 1.10840866 |
| 60 | MP0000266_abnormal_heart_morphology | 1.09869882 |
| 61 | MP0001879_abnormal_lymphatic_vessel | 1.08239810 |
| 62 | MP0000003_abnormal_adipose_tissue | 1.06222978 |
| 63 | MP0001958_emphysema | 1.05061606 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.02098109 |
| 65 | MP0001661_extended_life_span | 1.00426131 |
| 66 | MP0009384_cardiac_valve_regurgitation | 0.99651515 |
| 67 | MP0000537_abnormal_urethra_morphology | 0.97476377 |
| 68 | MP0005248_abnormal_Harderian_gland | 0.96034808 |
| 69 | MP0006054_spinal_hemorrhage | 0.93412895 |
| 70 | MP0010678_abnormal_skin_adnexa | 0.93407492 |
| 71 | MP0000569_abnormal_digit_pigmentation | 0.92502210 |
| 72 | MP0002128_abnormal_blood_circulation | 0.89118752 |
| 73 | MP0000920_abnormal_myelination | 0.86544886 |
| 74 | MP0005595_abnormal_vascular_smooth | 0.85085246 |
| 75 | MP0005171_absent_coat_pigmentation | 0.83485197 |
| 76 | MP0000343_altered_response_to | 0.82585454 |
| 77 | MP0004858_abnormal_nervous_system | 0.82352251 |
| 78 | MP0003300_gastrointestinal_ulcer | 0.82015241 |
| 79 | MP0002925_abnormal_cardiovascular_devel | 0.81139715 |
| 80 | MP0010030_abnormal_orbit_morphology | 0.80596783 |
| 81 | MP0000428_abnormal_craniofacial_morphol | 0.77206727 |
| 82 | MP0000383_abnormal_hair_follicle | 0.76879472 |
| 83 | MP0000767_abnormal_smooth_muscle | 0.75979916 |
| 84 | MP0001915_intracranial_hemorrhage | 0.75081467 |
| 85 | MP0009840_abnormal_foam_cell | 0.74206425 |
| 86 | MP0000762_abnormal_tongue_morphology | 0.73680654 |
| 87 | MP0005058_abnormal_lysosome_morphology | 0.72786740 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.71826365 |
| 89 | MP0001849_ear_inflammation | 0.70415292 |
| 90 | MP0008260_abnormal_autophagy | 0.69598160 |
| 91 | MP0005164_abnormal_response_to | 0.69564787 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.69507516 |
| 93 | MP0005165_increased_susceptibility_to | 0.69127068 |
| 94 | MP0001542_abnormal_bone_strength | 0.69020367 |
| 95 | MP0002133_abnormal_respiratory_system | 0.68782548 |
| 96 | MP0005388_respiratory_system_phenotype | 0.68782548 |
| 97 | MP0000462_abnormal_digestive_system | 0.67823642 |
| 98 | MP0003941_abnormal_skin_development | 0.67764070 |
| 99 | MP0002090_abnormal_vision | 0.66593692 |
| 100 | MP0001614_abnormal_blood_vessel | 0.65861656 |
| 101 | MP0000534_abnormal_ureter_morphology | 0.64926014 |
| 102 | MP0003045_fibrosis | 0.64407680 |
| 103 | MP0002168_other_aberrant_phenotype | 0.64248381 |
| 104 | MP0005551_abnormal_eye_electrophysiolog | 0.64175548 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.64066591 |
| 106 | MP0005187_abnormal_penis_morphology | 0.63146352 |
| 107 | MP0009780_abnormal_chondrocyte_physiolo | 0.63053669 |
| 108 | MP0000579_abnormal_nail_morphology | 0.62258341 |
| 109 | MP0005167_abnormal_blood-brain_barrier | 0.59598983 |
| 110 | MP0004043_abnormal_pH_regulation | 0.59461190 |
| 111 | MP0010234_abnormal_vibrissa_follicle | 0.56955472 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.56164491 |
| 113 | MP0003011_delayed_dark_adaptation | 0.56064894 |
| 114 | MP0006072_abnormal_retinal_apoptosis | 0.55810482 |
| 115 | MP0003690_abnormal_glial_cell | 0.55804341 |
| 116 | MP0002971_abnormal_brown_adipose | 0.54950856 |
| 117 | MP0001784_abnormal_fluid_regulation | 0.53974387 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 0.53596251 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.52761006 |
| 120 | MP0003091_abnormal_cell_migration | 0.52488918 |
| 121 | MP0002877_abnormal_melanocyte_morpholog | 0.52236154 |
| 122 | MP0003935_abnormal_craniofacial_develop | 0.52087732 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.51854158 |
| 124 | MP0000467_abnormal_esophagus_morphology | 0.51443997 |
| 125 | MP0002060_abnormal_skin_morphology | 0.51261543 |
| 126 | MP0002295_abnormal_pulmonary_circulatio | 0.50227345 |
| 127 | MP0003634_abnormal_glial_cell | 0.49893259 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.36260749 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 5.64838002 |
| 3 | Muscle fiber splitting (HP:0003555) | 5.55904149 |
| 4 | Ventricular tachycardia (HP:0004756) | 5.49084295 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 5.43738107 |
| 6 | Exercise-induced myalgia (HP:0003738) | 5.40408601 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 5.14255989 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 4.99929230 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.94735112 |
| 10 | Atrial fibrillation (HP:0005110) | 4.73336434 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 4.68289597 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 4.34434832 |
| 13 | Difficulty running (HP:0009046) | 4.32072946 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.28883142 |
| 15 | Subaortic stenosis (HP:0001682) | 4.28883142 |
| 16 | Lipoatrophy (HP:0100578) | 4.23006493 |
| 17 | Increased connective tissue (HP:0009025) | 4.20045391 |
| 18 | Supraventricular tachycardia (HP:0004755) | 4.13717084 |
| 19 | Supraventricular arrhythmia (HP:0005115) | 4.11396390 |
| 20 | Myoglobinuria (HP:0002913) | 3.96189657 |
| 21 | EMG: myopathic abnormalities (HP:0003458) | 3.94671685 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 3.85021160 |
| 23 | Protrusio acetabuli (HP:0003179) | 3.80032708 |
| 24 | Syncope (HP:0001279) | 3.79567328 |
| 25 | Prolonged QT interval (HP:0001657) | 3.65326668 |
| 26 | Muscle fiber inclusion bodies (HP:0100299) | 3.60672543 |
| 27 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.54444765 |
| 28 | Dilated cardiomyopathy (HP:0001644) | 3.52495316 |
| 29 | Ventricular arrhythmia (HP:0004308) | 3.44559278 |
| 30 | Broad metatarsal (HP:0001783) | 3.35341213 |
| 31 | Bundle branch block (HP:0011710) | 3.27956682 |
| 32 | Premature rupture of membranes (HP:0001788) | 3.13404726 |
| 33 | Asymmetric septal hypertrophy (HP:0001670) | 3.11687045 |
| 34 | Aortic aneurysm (HP:0004942) | 3.11022201 |
| 35 | Ventricular fibrillation (HP:0001663) | 3.08980514 |
| 36 | Increased variability in muscle fiber diameter (HP:0003557) | 3.05433936 |
| 37 | Palpitations (HP:0001962) | 2.98799644 |
| 38 | Nemaline bodies (HP:0003798) | 2.95418584 |
| 39 | Scapular winging (HP:0003691) | 2.92414893 |
| 40 | Arterial tortuosity (HP:0005116) | 2.88856443 |
| 41 | Vascular tortuosity (HP:0004948) | 2.88346750 |
| 42 | Myotonia (HP:0002486) | 2.84963366 |
| 43 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.81406992 |
| 44 | Heart block (HP:0012722) | 2.74516431 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.73629642 |
| 46 | Difficulty climbing stairs (HP:0003551) | 2.70690883 |
| 47 | Ulnar deviation of the wrist (HP:0003049) | 2.68754148 |
| 48 | Central scotoma (HP:0000603) | 2.67700811 |
| 49 | Atrioventricular block (HP:0001678) | 2.66869239 |
| 50 | Abnormal atrioventricular conduction (HP:0005150) | 2.64329516 |
| 51 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.59858810 |
| 52 | Aortic dissection (HP:0002647) | 2.58913884 |
| 53 | Neck muscle weakness (HP:0000467) | 2.57402949 |
| 54 | Muscle stiffness (HP:0003552) | 2.56294991 |
| 55 | Hypoplastic ischia (HP:0003175) | 2.44932289 |
| 56 | Abnormal EKG (HP:0003115) | 2.42529751 |
| 57 | Abnormality of the foot musculature (HP:0001436) | 2.35368546 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.35161409 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.35161409 |
| 60 | Round ear (HP:0100830) | 2.29815184 |
| 61 | Foot dorsiflexor weakness (HP:0009027) | 2.25947730 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.24122088 |
| 63 | Fragile skin (HP:0001030) | 2.22830106 |
| 64 | Shallow orbits (HP:0000586) | 2.20199767 |
| 65 | Gowers sign (HP:0003391) | 2.19446739 |
| 66 | Limb-girdle muscle atrophy (HP:0003797) | 2.14656518 |
| 67 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.13664075 |
| 68 | Mitral stenosis (HP:0001718) | 2.12873190 |
| 69 | Spinal rigidity (HP:0003306) | 2.12483376 |
| 70 | Abnormality of the ischium (HP:0003174) | 2.12196119 |
| 71 | Cerebral aneurysm (HP:0004944) | 2.10767271 |
| 72 | Palmoplantar keratoderma (HP:0000982) | 2.08281563 |
| 73 | Wormian bones (HP:0002645) | 2.06814894 |
| 74 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.06547969 |
| 75 | Slender build (HP:0001533) | 2.05796258 |
| 76 | Distal lower limb amyotrophy (HP:0008944) | 2.04591379 |
| 77 | Overgrowth (HP:0001548) | 2.03886846 |
| 78 | Calcaneovalgus deformity (HP:0001848) | 2.01928089 |
| 79 | Cervical subluxation (HP:0003308) | 2.00600541 |
| 80 | Limited hip movement (HP:0008800) | 2.00093036 |
| 81 | Scotoma (HP:0000575) | 1.97293235 |
| 82 | Lymphangioma (HP:0100764) | 1.97095280 |
| 83 | Proximal amyotrophy (HP:0007126) | 1.96525310 |
| 84 | Muscular dystrophy (HP:0003560) | 1.95541059 |
| 85 | Vertebral compression fractures (HP:0002953) | 1.92287132 |
| 86 | Frequent falls (HP:0002359) | 1.90594834 |
| 87 | Hamartoma of the eye (HP:0010568) | 1.90460519 |
| 88 | Mitral valve prolapse (HP:0001634) | 1.89535525 |
| 89 | Sudden cardiac death (HP:0001645) | 1.89084801 |
| 90 | Dilatation of the ascending aorta (HP:0005111) | 1.87489754 |
| 91 | Dysmetric saccades (HP:0000641) | 1.86247376 |
| 92 | Lower limb amyotrophy (HP:0007210) | 1.85788488 |
| 93 | Abnormality of the salivary glands (HP:0010286) | 1.84903274 |
| 94 | Peritonitis (HP:0002586) | 1.84412173 |
| 95 | Distal arthrogryposis (HP:0005684) | 1.83925477 |
| 96 | Rimmed vacuoles (HP:0003805) | 1.83553283 |
| 97 | EMG: neuropathic changes (HP:0003445) | 1.83325652 |
| 98 | Bladder diverticulum (HP:0000015) | 1.81541174 |
| 99 | Hip contracture (HP:0003273) | 1.78963531 |
| 100 | Advanced eruption of teeth (HP:0006288) | 1.77253773 |
| 101 | Myopathic facies (HP:0002058) | 1.77114602 |
| 102 | Deformed tarsal bones (HP:0008119) | 1.76027852 |
| 103 | Cardiovascular calcification (HP:0011915) | 1.75656588 |
| 104 | Abnormality of the calcaneus (HP:0008364) | 1.73473273 |
| 105 | Hypoplasia of the iris (HP:0007676) | 1.73228831 |
| 106 | Left ventricular hypertrophy (HP:0001712) | 1.72042617 |
| 107 | Limb-girdle muscle weakness (HP:0003325) | 1.70718337 |
| 108 | Natal tooth (HP:0000695) | 1.69390353 |
| 109 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.69387101 |
| 110 | Aneurysm (HP:0002617) | 1.68888067 |
| 111 | Pulmonary artery stenosis (HP:0004415) | 1.67796059 |
| 112 | Milia (HP:0001056) | 1.66903992 |
| 113 | Ankle contracture (HP:0006466) | 1.64952690 |
| 114 | Ketoacidosis (HP:0001993) | 1.64589958 |
| 115 | Visceral angiomatosis (HP:0100761) | 1.63724099 |
| 116 | Generalized muscle weakness (HP:0003324) | 1.61218842 |
| 117 | Rectal prolapse (HP:0002035) | 1.59757162 |
| 118 | Mitral regurgitation (HP:0001653) | 1.59657268 |
| 119 | Vertebral arch anomaly (HP:0008438) | 1.59605474 |
| 120 | Soft skin (HP:0000977) | 1.59496161 |
| 121 | Atrophic scars (HP:0001075) | 1.58928869 |
| 122 | Congestive heart failure (HP:0001635) | 1.55842437 |
| 123 | Hemangiomatosis (HP:0007461) | 1.55319934 |
| 124 | Rapidly progressive (HP:0003678) | 1.54772245 |
| 125 | Ankyloglossia (HP:0010296) | 1.54632404 |
| 126 | Achilles tendon contracture (HP:0001771) | 1.54587634 |
| 127 | Insidious onset (HP:0003587) | 1.54269199 |
| 128 | Termporal pattern (HP:0011008) | 1.54269199 |
| 129 | Flat acetabular roof (HP:0003180) | 1.52941800 |
| 130 | Conjunctival hamartoma (HP:0100780) | 1.52006121 |
| 131 | Pigmentary retinal degeneration (HP:0001146) | 1.50517771 |
| 132 | Facial diplegia (HP:0001349) | 1.50423146 |
| 133 | Hypoglycemic coma (HP:0001325) | 1.48688962 |
| 134 | Areflexia of lower limbs (HP:0002522) | 1.48661505 |
| 135 | Steppage gait (HP:0003376) | 1.48235825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.93774883 |
| 2 | OBSCN | 4.10841068 |
| 3 | DMPK | 3.29742400 |
| 4 | PHKG2 | 3.26009187 |
| 5 | PHKG1 | 3.26009187 |
| 6 | LMTK2 | 3.19504035 |
| 7 | PKN2 | 2.64081995 |
| 8 | TRIB3 | 2.52918562 |
| 9 | EPHB1 | 2.32776445 |
| 10 | RIPK1 | 2.28803783 |
| 11 | MYLK | 2.11423415 |
| 12 | STK39 | 1.86347952 |
| 13 | PIK3CA | 1.84459768 |
| 14 | TIE1 | 1.81049967 |
| 15 | NEK1 | 1.80135103 |
| 16 | NEK9 | 1.76029742 |
| 17 | AKT3 | 1.69580534 |
| 18 | LATS1 | 1.65717063 |
| 19 | CAMK1D | 1.60946406 |
| 20 | PDK3 | 1.52804137 |
| 21 | PDK4 | 1.52804137 |
| 22 | MAP3K2 | 1.47034355 |
| 23 | CAMK1G | 1.41129521 |
| 24 | FGFR2 | 1.37370115 |
| 25 | PTK6 | 1.35302683 |
| 26 | STK24 | 1.34536927 |
| 27 | PRKD1 | 1.32475680 |
| 28 | MET | 1.30936962 |
| 29 | ICK | 1.24656976 |
| 30 | MAP3K7 | 1.23301293 |
| 31 | CDK12 | 1.22863742 |
| 32 | ILK | 1.22485186 |
| 33 | TRPM7 | 1.20716712 |
| 34 | MAP3K6 | 1.20613562 |
| 35 | PAK3 | 1.16481713 |
| 36 | PDGFRA | 1.15206768 |
| 37 | WNK1 | 1.12634634 |
| 38 | PDK2 | 1.10205985 |
| 39 | CAMK2D | 1.09073303 |
| 40 | NTRK1 | 1.06509043 |
| 41 | PKN1 | 1.06241623 |
| 42 | FGFR3 | 1.04884922 |
| 43 | MAPK7 | 1.04316255 |
| 44 | ERN1 | 1.03599883 |
| 45 | MOS | 1.03206072 |
| 46 | ROCK2 | 1.02676159 |
| 47 | SGK3 | 1.02326365 |
| 48 | ROCK1 | 1.02317920 |
| 49 | SIK1 | 1.01700038 |
| 50 | FGFR4 | 0.97683120 |
| 51 | PBK | 0.96949142 |
| 52 | PINK1 | 0.95856916 |
| 53 | WNK4 | 0.93395284 |
| 54 | MUSK | 0.93282167 |
| 55 | MAP3K10 | 0.89853720 |
| 56 | CDC42BPA | 0.88772657 |
| 57 | FER | 0.87994420 |
| 58 | PRKAA2 | 0.86726585 |
| 59 | BCKDK | 0.84835929 |
| 60 | TGFBR2 | 0.84031928 |
| 61 | MAP3K1 | 0.82711771 |
| 62 | INSRR | 0.80490002 |
| 63 | PRPF4B | 0.76826020 |
| 64 | LIMK1 | 0.75553367 |
| 65 | LRRK2 | 0.75123924 |
| 66 | EPHA3 | 0.74630640 |
| 67 | MTOR | 0.72696163 |
| 68 | PRKAA1 | 0.72408604 |
| 69 | DDR2 | 0.72243138 |
| 70 | PAK6 | 0.72220401 |
| 71 | BMX | 0.71918362 |
| 72 | EPHB2 | 0.71731620 |
| 73 | MAPK12 | 0.70562962 |
| 74 | SGK2 | 0.70462307 |
| 75 | MAP2K3 | 0.70365414 |
| 76 | PAK2 | 0.68605589 |
| 77 | MAP2K1 | 0.67709500 |
| 78 | PDGFRB | 0.66799935 |
| 79 | EEF2K | 0.65863231 |
| 80 | PAK4 | 0.64369576 |
| 81 | PRKD2 | 0.64030332 |
| 82 | MAP3K3 | 0.62721760 |
| 83 | MAP2K4 | 0.60899748 |
| 84 | FGFR1 | 0.58313224 |
| 85 | CAMK4 | 0.56036565 |
| 86 | ERBB2 | 0.55573761 |
| 87 | JAK1 | 0.53831025 |
| 88 | DYRK1B | 0.52194560 |
| 89 | MAPKAPK3 | 0.51538952 |
| 90 | ZAP70 | 0.50157673 |
| 91 | EPHA2 | 0.50067454 |
| 92 | RET | 0.49190286 |
| 93 | RAF1 | 0.49060274 |
| 94 | PRKG2 | 0.48732348 |
| 95 | PTK2B | 0.48629251 |
| 96 | GSK3A | 0.48483130 |
| 97 | PRKACB | 0.48438981 |
| 98 | PRKD3 | 0.45612234 |
| 99 | PTK2 | 0.45542505 |
| 100 | STK4 | 0.45398917 |
| 101 | KSR1 | 0.45228973 |
| 102 | SGK223 | 0.44914057 |
| 103 | SGK494 | 0.44914057 |
| 104 | OXSR1 | 0.43789918 |
| 105 | AKT2 | 0.43500864 |
| 106 | RPS6KA2 | 0.42946005 |
| 107 | IRAK3 | 0.42681016 |
| 108 | STK3 | 0.40093835 |
| 109 | TGFBR1 | 0.40086131 |
| 110 | STK38L | 0.39050973 |
| 111 | RPS6KC1 | 0.37923774 |
| 112 | RPS6KL1 | 0.37923774 |
| 113 | MELK | 0.37729507 |
| 114 | MARK2 | 0.37585555 |
| 115 | MAPK10 | 0.37327320 |
| 116 | CAMK2G | 0.37250733 |
| 117 | PDPK1 | 0.36561089 |
| 118 | SCYL2 | 0.36051191 |
| 119 | STK38 | 0.35970584 |
| 120 | RPS6KB1 | 0.35816836 |
| 121 | PRKCH | 0.35353693 |
| 122 | LATS2 | 0.34893205 |
| 123 | MST1R | 0.34856427 |
| 124 | DAPK3 | 0.34296945 |
| 125 | MAPK4 | 0.32819710 |
| 126 | KSR2 | 0.32281258 |
| 127 | PRKCE | 0.32005854 |
| 128 | CSNK1D | 0.31695342 |
| 129 | PIK3CG | 0.31068940 |
| 130 | RPS6KB2 | 0.30571402 |
| 131 | RPS6KA6 | 0.30400034 |
| 132 | PRKG1 | 0.29896235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.70020204 |
| 2 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.64781654 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.55399375 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.97144050 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.96668134 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.89896256 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.24390785 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13935982 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86736511 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.79148783 |
| 11 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73991043 |
| 12 | Focal adhesion_Homo sapiens_hsa04510 | 1.65859482 |
| 13 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63815150 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.62853384 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.60734166 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.60070054 |
| 17 | Tight junction_Homo sapiens_hsa04530 | 1.58291234 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.51495522 |
| 19 | Insulin resistance_Homo sapiens_hsa04931 | 1.31369056 |
| 20 | Adherens junction_Homo sapiens_hsa04520 | 1.27876177 |
| 21 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.26205298 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.22239592 |
| 23 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.21763732 |
| 24 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.18285495 |
| 25 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17585956 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15128529 |
| 27 | Endometrial cancer_Homo sapiens_hsa05213 | 1.14542760 |
| 28 | Lysine degradation_Homo sapiens_hsa00310 | 1.12949504 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.11123959 |
| 30 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09258301 |
| 31 | Amoebiasis_Homo sapiens_hsa05146 | 1.06300077 |
| 32 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01246541 |
| 33 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00779395 |
| 34 | Glioma_Homo sapiens_hsa05214 | 0.99502709 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.98788192 |
| 36 | Other glycan degradation_Homo sapiens_hsa00511 | 0.96527040 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.94838280 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.93528050 |
| 39 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.93399799 |
| 40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92272354 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91650901 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91640799 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90524346 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 0.90247121 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.89641330 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89230989 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.88854995 |
| 48 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.87875276 |
| 49 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87814689 |
| 50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86080391 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.86027691 |
| 52 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.85236029 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83990508 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83857614 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.83172246 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.82575038 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.82323227 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82199115 |
| 59 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81605140 |
| 60 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79955975 |
| 61 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.79773582 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79674741 |
| 63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.79278477 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.79240007 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79195713 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.77304767 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76929387 |
| 68 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75760790 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75724850 |
| 70 | Phototransduction_Homo sapiens_hsa04744 | 0.75289743 |
| 71 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.74585630 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72828195 |
| 73 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.71837842 |
| 74 | Parkinsons disease_Homo sapiens_hsa05012 | 0.71659822 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.71225239 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70943833 |
| 77 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.70763964 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70660950 |
| 79 | Prostate cancer_Homo sapiens_hsa05215 | 0.69450471 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.69094279 |
| 81 | Bile secretion_Homo sapiens_hsa04976 | 0.68578294 |
| 82 | Melanoma_Homo sapiens_hsa05218 | 0.67624575 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.67544565 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.67385888 |
| 85 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67132352 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.64258339 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63568042 |
| 88 | Gap junction_Homo sapiens_hsa04540 | 0.63343419 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63191040 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63093330 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.62385004 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.61910839 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61502747 |
| 94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.60851804 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60548493 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60530025 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60499838 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58993957 |
| 99 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58448475 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.58113906 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57036756 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56914515 |
| 103 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.54518424 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53825547 |
| 105 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53802449 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52174386 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52004520 |
| 108 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50923482 |
| 109 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50712926 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50170383 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.49670793 |
| 112 | Long-term depression_Homo sapiens_hsa04730 | 0.49634016 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49558419 |
| 114 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49213419 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48786552 |
| 116 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47925084 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47892217 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47620926 |
| 119 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47341470 |
| 120 | Salivary secretion_Homo sapiens_hsa04970 | 0.46495861 |
| 121 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46016954 |
| 122 | Melanogenesis_Homo sapiens_hsa04916 | 0.45485943 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44816144 |
| 124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44796521 |
| 125 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44132062 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.43864422 |
| 127 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43645783 |
| 128 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42145665 |
| 129 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40973422 |
| 130 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40518511 |
| 131 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.40493917 |
| 132 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39036041 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37825939 |
| 134 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37500634 |

